Saxo Market Call cover image

Forecasts for 2026. Also: a stab at assembling a 2026 portfolio.

Saxo Market Call

00:00

Novo Nordisk's US approval news

John Hardy explains Wagovi pill approval and implications for Novo Nordisk's diabetes/obesity franchise.

Play episode from 02:18
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app